<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04483128</url>
  </required_header>
  <id_info>
    <org_study_id>CIFSNA2020</org_study_id>
    <nct_id>NCT04483128</nct_id>
  </id_info>
  <brief_title>Electrical Stimulation With Interferential Current in the Non-especific Chronic Low Back Pain: Effects on the Autonomic Nervous System.</brief_title>
  <official_title>Electrical Stimulation With Interferential Current in the Non-especific Chronic Low Back Pain: Effects on the Autonomic Nervous System.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Seville</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Seville</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study it's to analyze the relationship between autonomic nervous system
      balance (ANSb) and chronic pain conditions, especially in this case, non-especific chronic
      low back pain (CLBP).

      Most of physiotherapy approaches focus only in biomechanical aspects, leaving aside what kind
      of factors could perpetuate CLBP. Since 1985, ANSb was studied due to its potential
      contribution to chronic pain.

      Electrical stimulation, through interferential currents (IFC), it's a safe and well-known
      therapy used in CLBP with good outcomes regarding pain relief.

      The main objective of this study it's to quantify the association between CLBP and ANSb
      alterations. In second place, the research team aims to record the influence of IFC over pain
      and ANSb in those subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the first place, a meeting will be organized with the patients to resolve any doubt about
      the study and its process. The investigators will make sure every instruction is
      understandable, giving enough time to read and ask pertinent questions.

      Secondly, patients will be provided of an informed consent specific for the present study,
      according to the legal forms. Participants must agree with all the information and sign the
      document.

      At this point, patients will be interviewed individually by a researcher to collect all the
      data regarding to the Clinical History in Physiotherapy.

      In the next step, patients will be randomized into two different groups by choosing one
      opaque envelope, containing a number for the allocation. A researcher will make the final
      allocation depending on the number. Patients were unaware of the group allocation for
      masking.

      This study has to possible groups with a common indication for both:

        1. Experimental group: Patients allocated in this group will receive one single session of
           interferential current (IFC). Current used a carrier frequency of 4.000 Hz, 65Hz of
           amplitude modulated frequency (AMF) with sweep frecuency of 95Hz in a 1:1 swing pattern
           (quadripolar technique). Intensity was adjusted according to patient's tolerance without
           visible muscle twitches. The session will last 25 min.

        2. Control group: This group will not receive any intervention. Patients will keep his
           general practitioner's indications about pharmacology.

        3. Common indication: Both groups will get instructions to perform a set of home-based
           exercises for core strengthening after variable collecting.

      Before and after the session, all the variable measurements will be collected in the same
      environmental conditions by the same researcher.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants diagnosed with chronic low back pain will be divided into two different groups with 28 patients each:
Experimental group: Participants in this group will receive electrical stimulation with interferential current. They will get also instructions to perform core strengthening exercises at home, after variable collection.
Control group: Participants in this group wont recieve any intervention. This group will only get instructions to perform core strengthening exercises at home (after variable collection) and follow General Practitioner indications about pharmacology.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Randomization process will be masked by opaques envelopes with numbers. Participants choose one random envelope, unaware the number and group relation. Later, a researcher will associate participants, groups and numbers.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Heart Rate variability (HRV-a)</measure>
    <time_frame>Evaluation before intervention (basal): 15 minutes before intervention, for 10 minutes.</time_frame>
    <description>Heart Rate variability (HRV) is measured by calculating mean HR, maximum HR and minimum HR. First Beat Bodyguard2 device will be used to collect HRV.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Heart Rate variability (HRV-b)</measure>
    <time_frame>Evaluation during the intervention: For 20 minutes, while the interferential current (intervention) is being applied.</time_frame>
    <description>Heart Rate variability (HRV) is measured by calculating mean HR, maximum HR and minimum HR. First Beat Bodyguard2 device will be used to collect HRV.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Root-mean-square differences of successive heartbeat intervals (RMSSD-a)</measure>
    <time_frame>Evaluation before intervention (basal): 15 minutes before intervention, for 10 minutes.</time_frame>
    <description>RMSSD it's an indirect indicator of parasympathic nervous system level of activity. First Beat Bodyguard2 device will be used to collect RMSSD.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Root-mean-square differences of successive heartbeat intervals (RMSSD-b)</measure>
    <time_frame>Evaluation during the intervention: For 20 minutes, while the interferential current (intervention) is being applied.</time_frame>
    <description>RMSSD it's an indirect indicator of parasympathic nervous system level of activity. First Beat Bodyguard2 device will be used to collect RMSSD.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Standard Deviation 1 (SD1-a)</measure>
    <time_frame>Evaluation before intervention (basal): 15 minutes before intervention, for 10 minutes.</time_frame>
    <description>SD1 is an indicator of the autonomic nervous balance. First Beat Bodyguard2 device will be used to collect it.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Standard Deviation 1 (SD1-b)</measure>
    <time_frame>Evaluation during the intervention: For 20 minutes, while the interferential current (intervention) is being applied.</time_frame>
    <description>SD1 is an indicator of the autonomic nervous balance. First Beat Bodyguard2 device will be used to collect it.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Standard Deviation 2 (SD2-a)</measure>
    <time_frame>Evaluation before intervention (basal): 15 minutes before intervention, for 10 minutes.</time_frame>
    <description>SD2 is an indicator of the autonomic nervous balance. First Beat Bodyguard2 device will be used to collect it.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Standard Deviation 2 (SD2-b)</measure>
    <time_frame>Evaluation during the intervention: For 20 minutes, while the interferential current (intervention) is being applied.s.</time_frame>
    <description>SD2 is an indicator of the autonomic nervous balance. First Beat Bodyguard2 device will be used to collect it.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stress Index (SS-a)</measure>
    <time_frame>Evaluation before intervention (basal): 15 minutes before intervention, for 10 minutes.</time_frame>
    <description>SS it's an indicator of sympathetic nervous system level of activation. First Beat Bodyguard2 device will be used to collect SS.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stress Index (SS-b)</measure>
    <time_frame>Evaluation during the intervention: For 20 minutes, while the interferential current (intervention) is being applied.s.</time_frame>
    <description>SS it's an indicator of sympathetic nervous system level of activation. First Beat Bodyguard2 device will be used to collect SS.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sympathetic / Parasympathetic Ratio (S/PS Ratio-a)</measure>
    <time_frame>Evaluation before intervention (basal): 15 minutes before intervention, for 10 minutes.</time_frame>
    <description>S/PS Ratio it's an indicator of autonomic nervous system balance. First Beat Bodyguard2 device will be used to collect S/PS Ratio.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sympathetic / Parasympathetic Ratio (S/PS Ratio-b)</measure>
    <time_frame>Evaluation during the intervention: For 20 minutes, while the interferential current (intervention) is being applied.s.</time_frame>
    <description>S/PS Ratio it's an indicator of autonomic nervous system balance. First Beat Bodyguard2 device will be used to collect S/PS Ratio.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Numeric Pain Rating Scale (NPRS-a)</measure>
    <time_frame>Evaluation before intervention (basal): 15 minutes before intervention.</time_frame>
    <description>NPRS it's an scale used to measure with ease, patient's perceived pain with a scoring of 0 (no pain) and 10 (maximum pain).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Numeric Pain Rating Scale (NPRS-b)</measure>
    <time_frame>Evaluation immediately after treatment session.</time_frame>
    <description>NPRS it's an scale used to measure with ease, patient's perceived pain with a scoring of 0 (no pain) and 10 (maximum pain).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Roland Morris Questionnaire (RMQ-a)</measure>
    <time_frame>Evaluation before intervention (basal): 15 minutes before intervention.</time_frame>
    <description>RMQ it's a questionnaire used to measure an individual level of disability related to low back pain, with a scoring of 0 (no disability at all) and 24 (maximum disability).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Roland Morris Questionnaire (RMQ-b)</measure>
    <time_frame>Evaluation immediately after treatment session.</time_frame>
    <description>RMQ it's a questionnaire used to measure an individual level of disability related to low back pain, with a scoring of 0 (no disability at all) and 24 (maximum disability).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Scale for Personal Psychological Apprehension (SPPA)</measure>
    <time_frame>Evaluation before intervention (basal): 15 minutes before intervention.</time_frame>
    <description>SPPA it's a questionnaire made to measure subject's susceptibility to receive electrical stimulation. A scoring of &gt;45 points indicates that subject shouldnt be treated with electrical therapy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dosimetry achieved with electrical stimulation</measure>
    <time_frame>Recorded immediately after treatment session.</time_frame>
    <description>Maximal dosimetry reached during the session will be recorded in mA.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">56</enrollment>
  <condition>Chronic Low-back Pain</condition>
  <condition>Chronic Pain</condition>
  <condition>Autonomic Imbalance</condition>
  <arm_group>
    <arm_group_label>Control group.</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This group it's only asked to:
Perform a basic set of core strengthening exercises at home
Continue with pharmacology indications by his general practitioner.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental group.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will recieve also instructions for core strengthening exercises and a single session of interferential current (IFC).
IFC parameters:
Carrier frequency of 4000 Hz
Amplitude modulated frequency of 65 Hz (AMF)
Sweep frequency of 95 Hz of modulation with a 1:1 swing pattern, in a quadripolar technique.
Intensity will depend on subjet's tolerance but without generate visible muscle twitches.
Session duration: 25 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electrical stimulation: Interferential Current (IFC)</intervention_name>
    <description>Application of IFC with Sonopuls 692Â® (Enraf-Nonius BV, Rotterdam, The Netherlands) device. Parameters:
Carrier frequency of 4000 Hz
Amplitude modulated frequency of 65 Hz (AMF)
Sweep frequency of 95 Hz of modulation with a 1:1 swing pattern, in a quadripolar technique.
Intensity will depend on subjet's tolerance but without generate visible muscle twitches.
Session duration: 25 minutes</description>
    <arm_group_label>Experimental group.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects diagnosed with cronic low back pain with at least 3 months of evolution.

          -  Subjects with a minimal pain of 3/10 according to NPRS

          -  Subjects with informed consent read and signed.

          -  Subjects not undergoing any other physical therapy intervention.

        Exclusion Criteria:

          -  Neurological, musculoskeletal or sensory affectations.

          -  Evidence of infectious process, fever or hypotension.

          -  Metallic implants in low back area or treated area

          -  No surgical interventions in low back area

          -  Not being under pharmacological treatment with influence in Autonomic Nervous System
             like antidepressants.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Manuel Albornoz Cabello</name>
      <address>
        <city>Sevilla</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manuel Albornoz Cabello, Doctor</last_name>
      <phone>607505490</phone>
      <phone_ext>+34</phone_ext>
      <email>malbornoz@us.es</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 14, 2020</study_first_submitted>
  <study_first_submitted_qc>July 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 23, 2020</study_first_posted>
  <last_update_submitted>July 20, 2020</last_update_submitted>
  <last_update_submitted_qc>July 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Seville</investigator_affiliation>
    <investigator_full_name>Dr. Manuel Albornoz Cabello</investigator_full_name>
    <investigator_title>Doctor in Physiotherapy (PhD)</investigator_title>
  </responsible_party>
  <keyword>electrical stimulation</keyword>
  <keyword>interferential current</keyword>
  <keyword>autonomic balance</keyword>
  <keyword>chronic low back pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

